Eli Lilly advances retatrutide as new weight-loss drug

The wire

1. 01Eli Lilly's retatrutide was reported as the company's new weight-loss drug.
2. 02Prescribers and operators tracking the incretin pipeline follow retatrutide as the leading triple-agonist candidate after tirzepatide.
3. 03Dosing, trial endpoints and regulatory timing are not set out in the report and would need the company's own trial disclosures.

From the source

eli lilly new weight loss drug retatrutide